Puma Biotechnology SG&A Expense (Quarterly) Insights

Puma Biotechnology Inc (PBYI)

5.03 +0.15 (+3.07%) USD | NASDAQ | Apr 26, 16:00

5.03 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	19.82M
September 30, 2023	22.18M
June 30, 2023	24.46M
March 31, 2023	22.49M
December 31, 2022	25.04M
September 30, 2022	23.96M
June 30, 2022	20.58M
March 31, 2022	20.40M
December 31, 2021	22.46M
September 30, 2021	26.08M
June 30, 2021	39.41M
March 31, 2021	28.24M
December 31, 2020	28.61M
September 30, 2020	29.60M
June 30, 2020	29.35M
March 31, 2020	30.94M
December 31, 2019	31.20M
September 30, 2019	31.40M
June 30, 2019	33.53M
March 31, 2019	45.51M
December 31, 2018	40.93M
September 30, 2018	28.50M
June 30, 2018	40.14M
March 31, 2018	36.60M
December 31, 2017	30.87M

Date	Value
September 30, 2017	32.49M
June 30, 2017	24.93M
March 31, 2017	18.40M
December 31, 2016	16.47M
September 30, 2016	14.02M
June 30, 2016	12.26M
March 31, 2016	11.04M
December 31, 2015	9.596M
September 30, 2015	8.809M
June 30, 2015	5.532M
March 31, 2015	7.871M
December 31, 2014	8.062M
September 30, 2014	3.867M
June 30, 2014	3.904M
March 31, 2014	3.525M
December 31, 2013	2.983M
September 30, 2013	2.263M
June 30, 2013	2.267M
March 31, 2013	2.274M
December 31, 2012	13.66M
September 30, 2012	8.094M
June 30, 2012	1.771M
March 31, 2012	1.284M
December 31, 2011	8.959M
September 30, 2011	0.3338M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

19.82M

Minimum

Dec 2023

39.41M

Maximum

Jun 2021

26.83M

Average

26.08M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks